Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population

被引:106
作者
Hamano, E
Hijikata, M
Itoyama, S
Quy, T
Phi, NC
Long, HT
Ha, L
Van Ban, V
Matsushita, I
Yanai, H
Kirikae, F
Kirikae, T
Kuratsuji, T
Sasazuki, T
Keicho, N
机构
[1] Department of Respiratory Diseases, Research Institute, Intl. Medical Center of Japan
[2] Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association
[3] Department of Infectious Diseases, Research Institute, Intl. Medical Center of Japan
[4] Research Institute, Intl. Medical Center of Japan
关键词
severe acute respiratory syndrome; SARS associated coronavirus; association study; polymorphism; oligoadenylate synthetase 1; myxovirus resistance-A; interferon; Vietnam;
D O I
10.1016/j.bbrc.2005.02.101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We hypothesized that host antiviral genes induced by type I interferons might affect the natural course of severe acute respiratory syndrome (SARS). We analyzed single nucleotide polymorphisms (SNPs) of 2',5'-oligoadenylate synthetase I (OAS-1), myxovirus resistance-A (MxA), and double-stranded RNA-dependent protein kinase in 44 Vietnamese SARS patients with 103 controls. The G-allele of non-synonymous A/G SNP in exon 3 of OAS-1 gene showed association with SARS (p = 0.0090). The G-allele in exon 3 of OAS-1 and the one in exon 6 were in strong linkage disequilibrium and both of them were associated with SARS infection. The GG genotype and G-allele of G/T SNP at position -88 in the MxA gene promoter were found more frequently in hypoxemic group than in non-hypoxemic group of SARS (p = 0.0195). Our findings suggest that polymorphisms of two IFN-inducible genes OAS-1 and MxA might affect susceptibility to the disease and progression of SARS at each level. 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1234 / 1239
页数:6
相关论文
共 32 条
[21]   TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATIONS OF EXOGENOUS HUMAN BETA INTERFERON GENE IN SIMIAN CELLS DEFECTIVE IN INTERFERON SYNTHESIS [J].
MOSCA, JD ;
PITHA, PM .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (06) :2279-2283
[22]   Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome [J].
Ng, MHL ;
Lau, KM ;
Li, L ;
Cheng, SH ;
Chan, WY ;
Hui, PK ;
Zee, B ;
Leung, CB ;
Sung, JJY .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (03) :515-518
[23]   Coronavirus as a possible cause of severe acute respiratory syndrome [J].
Peiris, JSM ;
Lai, ST ;
Poon, LLM ;
Guan, Y ;
Yam, LYC ;
Lim, W ;
Nicholls, J ;
Yee, WKS ;
Yan, WW ;
Cheung, MT ;
Cheng, VCC ;
Chan, KH ;
Tsang, DNC ;
Yung, RWH ;
Ng, TK ;
Yuen, KY .
LANCET, 2003, 361 (9366) :1319-1325
[24]   The human 2′,5′-oligoadenylate synthetase family:: Interferon-induced proteins with unique enzymatic properties [J].
Rebouillat, D ;
Hovanessian, AG .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (04) :295-308
[25]   Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) [J].
Sainz, B ;
Mossel, EC ;
Peters, CJ ;
Garry, RF .
VIROLOGY, 2004, 329 (01) :11-17
[26]   Antiviral actions of interferons [J].
Samuel, CE .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :778-809
[27]   The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein [J].
Spiegel, M ;
Pichlmair, A ;
Mühlberger, E ;
Haller, O ;
Weber, F .
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (03) :211-213
[28]   Severe acute respiratory syndrome related coronavirus is inhibited by interferon-α [J].
Ströher, U ;
DiCaro, A ;
Li, Y ;
Strong, JE ;
Aoki, F ;
Plummer, F ;
Jones, SM ;
Feldmann, H .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07) :1164-1167
[29]   Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection [J].
Suzuki, F ;
Arase, Y ;
Suzuki, Y ;
Tsubota, A ;
Akuta, N ;
Hosaka, T ;
Someya, T ;
Kobayashi, M ;
Saitoh, S ;
Ikeda, K ;
Kobayashi, M ;
Matsuda, M ;
Takagi, K ;
Satoh, J ;
Kumada, H .
JOURNAL OF VIRAL HEPATITIS, 2004, 11 (03) :271-276
[30]   Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs [J].
Tan, ELC ;
Ooi, EE ;
Lin, CY ;
Tan, HC ;
Ling, AE ;
Lim, B ;
Stanton, LW .
EMERGING INFECTIOUS DISEASES, 2004, 10 (04) :581-586